Full-Time

Senior Industrial Designer

Posted on 4/16/2025

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

No salary listed

Senior

Sydney NSW, Australia

Category
Industrial Design
UI/UX & Design
Required Skills
Product Design
Requirements
  • Demonstrated expertise in product design, development, and volume manufacturing.
  • Minimum of 5 years of related experience
  • Proven experience in consumer-centric product design.
  • Deep understanding of Colour, Material, Finish (CMF).
  • Knowledge of manufacturing processes & materials for diverse product types—wearables & textile integration experience highly desirable.
  • Expertise in Design for Manufacturing (DFM) & Design for Assembly (DFA).
  • Experience working within strict quality systems & regulatory environments.
  • Demonstrated success in team or studio environments.
  • Degree or Tertiary Qualification in Product Design, Industrial Design, or equivalent.
Responsibilities
  • Support the mission to transform the product portfolio and enhance the experience of the people we serve.
  • Collaborate with diverse, hard-working teams of designers, engineers, and creatives to deliver world-class, transformational products and customer experiences.
  • Shape strategy, technology, and processes to achieve Resmed’s vision.
Desired Qualifications
  • Passion for evolving capabilities and staying ahead of emerging trends.

ResMed develops medical devices and software platforms designed to treat and manage conditions like sleep apnea and COPD, as well as other chronic diseases. Their products are cloud-connected, allowing for better monitoring and management of patient health. ResMed serves patients, healthcare professionals, and caregivers, focusing on improving care and enhancing quality of life. Unlike many competitors, ResMed combines device sales with software subscriptions, creating a recurring revenue model that supports ongoing patient care. The company's goal is to reduce hospital visits and lower healthcare costs while providing effective solutions for chronic disease management.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing telehealth adoption boosts demand for ResMed's cloud-connected solutions.
  • The sleep apnea devices market is projected to grow at a 7.8% CAGR until 2028.
  • Rising chronic respiratory diseases increase demand for ResMed's COPD management solutions.

What critics are saying

  • Emerging startups in home sleep apnea testing could impact ResMed's market share.
  • AI-driven diagnostic advancements may outpace ResMed's current technology offerings.
  • Semiconductor shortages could delay production of ResMed's cloud-connected devices.

What makes Resmed unique

  • ResMed offers cloud-connected medical devices for sleep apnea and chronic disease management.
  • The company provides software platforms enhancing patient care and reducing healthcare costs.
  • ResMed operates in over 120 countries, ensuring a broad global reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.

Medtrade
Apr 4th, 2025
Resmed Launches New Home Sleep Apnea Test

SAN DIEGO - Medtrade exhibitor Resmed has launched NightOwl(TM), a new home sleep apnea test (HSAT) that is now available across the United States.

MPO Magazine
Apr 3rd, 2025
Resmed Launches NightOwl Home Sleep Apnea Test

Resmed has launched its NightOwl home sleep apnea test (HSAT) in the U.S.

MarketBeat
Feb 28th, 2025
Proficio Capital Partners LLC Invests $50.36 Million in ResMed Inc. (NYSE:RMD)

Proficio Capital Partners LLC invests $50.36 million in ResMed Inc. (NYSE:RMD).

Healthier Tomorrow
Feb 26th, 2025
ResMed Survey: Despite Sleep Problems, Few Willing to Take Proactive Steps

ResMed today unveiled the findings of its fifth annual Global Sleep Survey.